OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 09/29/2023
Week ended 09/29/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 09/29/2023
- The Only Closed M&A Deal of the Week:
- On September 29, 2023, Psilobrain, a private Canadian Biotech/Pharma company, announced the closing of its acquisition of U.K.-based Vitality CBD Limited, a subsidiary of Yooma Wellness (YOOM: CSE)(YOOM: AQSE) for total consideration of $2M.
- After the sale, Yooma will no longer have any substantial operating assets and is facing a liquidity crisis.
Week ended 09/29/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.